Assessing the Irritation and Sensitization Potential of Transdermal and Topical Delivery Systems for ANDAs; Revised Draft Guidance for Industry; Availability

FDA-2018-D-3546-0012Other
Comments
0
Awaiting comments
Deadline
Closed on Jun 13, 2023
Closed Jun 13, 2023
Net supportiSupport minus oppose · campaigns included
Document

Details

The document's own metadata, straight from the source system.

Title
Assessing the Irritation and Sensitization Potential of Transdermal and Topical Delivery Systems for ANDAs; Revised Draft Guidance for Industry; Availability
Posted
Apr 13, 2023
Comment period
Apr 13, 2023 – Jun 13, 2023
Analysis

Overview

No comments yet.

Comments

Explorer

Every mirrored comment — filter by stance, campaign, or issue.

Filter:

No comments match.